Trovagene, Inc.
Records under this name other than patents Trovagene, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,501,924 | Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,909,118 | Compositions, Methods and Kits for Isolating Nucleic Acids from Body Fluids Using Anion Exchange Media Formerly held In force · High confidence | In force | High confidence | |
| US 8,222,370 | Nucleophosmin Protein (NPM) Mutants, Corresponding Gene Sequences and Uses Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 9,163,229 | Compositions, methods and kits for isolating nucleic acids from body fluids using anion exchange media Formerly held In force · High confidence | In force | High confidence | |
| US 9,725,767 | Nucleophosmin Protein (NPM) Mutants, Corresponding Gene Sequences and Uses Thereof Formerly held Term ended Term ended Oct 28, 2025 · High confidence | Term ended | Term ended Oct 28, 2025 | High confidence |
| US 10,155,989 | Nucleophosmin Protein (NPM) Mutants, Corresponding Gene Sequences and Uses Thereof Formerly held Term ended Term ended Oct 28, 2025 · High confidence | Term ended | Term ended Oct 28, 2025 | High confidence |
| US 10,487,366 | Nucleophosmin Protein (NPM) Mutants, Corresponding Gene Sequences and Uses Thereof Formerly held Term ended Term ended Oct 28, 2025 · High confidence | Term ended | Term ended Oct 28, 2025 | High confidence |
| US 7,803,929 | Kits for diagnosis and monitoring of pathogenic infection by analysis of cell-free pathogenic nucleic acids in urine Lapsed on the fee record Ended Sep 28, 2022 · From the USPTO record | Lapsed on the fee record | Ended Sep 28, 2022 | From the USPTO record |
| US 8,642,261 | Genetic Marker for Detection of Human Papillomavirus Formerly held Lapsed on the fee record Ended Feb 4, 2022 · High confidence | Lapsed on the fee record | Ended Feb 4, 2022 | High confidence |
| US 9,816,148 | Amplification and Sequencing of Transrenal Nucleic Acids Formerly held Lapsed on the fee record Ended Nov 14, 2021 · Medium confidence | Lapsed on the fee record | Ended Nov 14, 2021 | Medium confidence |